• US: +1 9176726599
  • Login

Vaccine Delivery Devices Market Status (2016-2020) and Forecast Market Analysis, Regional Outlook, Segment Growth Potential, and Competitive Market Share Analysis, 2021-2027

Format: PDF | Pages: 254 | Report ID: MRS1145


Report Description

The global Vaccine Delivery Devices market size is estimated at USD 5,100.4 million in 2020, expanding at a CAGR 11.8% from 2021-2027 to reach 6,908.4 million USD in 2027.

Market Dynamics

The industry is being driven by expanding vaccination campaigns, increasing vaccine efforts and promotions, and growing sickness rates throughout the globe. For instance, the GAVI Alliance as well as the Bill & Melinda Gates Organization aggressively engage in vaccination programs, which are expected to significantly benefit the industry.

The increasing monetary support from the administration, as well as non-governmental institutions, has culminated in a spate of new advancements in the sector, hence increasing the industry's growth. The UK administration, for instance, has given the Medical Research Council £1 million from the International Problems Research Institute to explore the Zika virus's spread and origins. Additionally, the global population of diabetes individuals is growing. As per the World Health Organization, the ailment affects 422 million individuals worldwide, and the industry is likely to grow over the projected timeframe.

Regional Insights

North America led the industry, accounting for a major percentage of total sales. Rising vaccination cover increased expenditures in Research and innovation for novel vaccinations, and the high frequency of contagious illnesses are all driving industry expansion. Furthermore, modern hospital infrastructures as well as widespread understanding throughout the general population and medical professionals have added to the industry's considerable position.

Due to a big client population, rising targeted demographic, significant unmet requirements, and improved facilities in the area, Asia Pacific is predicted to develop the quickest throughout the next several years. Illness incidence is increasing due to an improper environment as well as an older population that is prone to contagious illnesses.

Segment Insights

Vaccine Administration Systems are classified into three categories: device, route of administration, and end-use. In regards to the route of administration, the intramuscular sector dominated the segment. The vast majority of immunizations are delivered intramuscularly. This method of administration lowers negative effects at the infusion site. Intramuscular needles are popular since they transport drugs deep within muscle cells, resulting in rapid circulation.

Based on the device type, the syringes category accounted for the lion's share of the industry. Vaccination is usually administered using syringes. Because they are affordable and reliable, they are widely employed in regular immunization and bulk vaccination campaigns.

Competitive Insights

The business is extremely divided, with the majority of rivals competing for bigger marketplaces. Worldwide vaccine delivery device companies use methods including partnership, collaboration, and mergers. The businesses invest significantly in developing their goods as well as in Research and innovation, giving them an advantage over their rivals and allowing them to increase their industry presence. As an example, Zealand Pharma paid USD 23 million for Valeritas Holdings, a pharmaceutical firm situated in the United States, in April 2020.

The report begins with an overview of the Industry Chain structure, and describes the industry environment, then analyses the market size and forecast of Vaccine Delivery Devices by-products, Route of Administration, Application, End-Use region, and Route of Administration. In addition, this report introduces the market competition situation among the vendors, and the company profile, besides, market price analysis, and value chain features are covered in this report.

Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):

  • West Pharmaceutical Services Inc.
  • Vaxxas Pty Ltd.
  • Theraject Inc.
  • Terumo Corp.
  • Smiths Medical
  • Schott Ag
  • Pharmajet
  • Nanopass Technologies Ltd.
  • Medical International Technologies (Mit Canada) Inc.
  • Kindeva Drug Delivery (Formerly 3M)
  • Ichor Medical Systems Inc.
  • Hindustan Syringes & Medical Devices Ltd.
  • Enesi Pharma
  • D'antonio Consultants International Inc.
  • Corium Inc.
  • BD
  • Apiject Systems Corp.

Device Coverage (Market Size & Forecast, Main Consumer Analysis, etc.):

  • Jet Injectors
  • Syringes
  • Others

Route of Administration Coverage (Market Size & Forecast, Main Consumer Analysis etc.):

  • Intramuscular Vaccination
  • Intradermal Vaccination
  • Subcutaneous Vaccination
  • Other Vaccinations

End-Use Coverage (Market Size & Forecast, Main Consumer Analysis etc.):

  • Clinics
  • Hospitals
  • Others

Region Coverage (Regional Consumption, Demand & Forecast by Countries etc.):

  • North America (U.S., and Canada)
  • Europe (Germany, U.K., France, Italy, Spain etc.)
  • Asia-Pacific (China, India, Japan, Indonesia, Malaysia, Australia, South Korea, etc.)
  • South America (Brazil, Mexico, Argentina etc.)
  • Middle East & Africa (Saudi Arabia, Kuwait, UAE, South Africa etc.)

Frequently Asked Questions

The global Vaccine Delivery Devices market size is estimated at USD 5,100.4 million in 2020, expanding at a CAGR 11.8% from 2021-2027 to reach 6,908.4 million USD in 2027.
North America captured the highest revenue in 2021 and is projected to continue its dominance during the study period.
The global Vaccine Delivery Devices market size is estimated at USD 5,100.4 million in 2020, expanding at a CAGR 11.8% from 2021-2027 to reach 6,908.4 million USD in 2027.
Asia Pacific (especially China, and India) region is projected to grow at the fastest growth rate during the study period.
The vaccine delivery device business is extremely divided, with the majority of rivals competing for bigger marketplaces. Worldwide vaccine delivery device companies use methods including partnership, collaboration, and mergers. The businesses invest significantly in developing their goods as well as in Research and innovation, giving them an advantage over their rivals and allowing them to increase their industry presence. As an example, Zealand Pharma paid USD 23 million for Valeritas Holdings, a pharmaceutical firm situated in the United States, in April 2020.

Why Choose Market Research Strategy?

  Authenticated Data Sources

We utilize market analysis/information from verified authenticated data sources to scoop accurate research reports

  Express Delivery

We understand the urgency of our clients and their clients' in the competitive space thus, deliver the report in minimum turnaround

  Gain Instant Access

Without further ado, choose us and get instant access to reliable analysis to help you make the right business decisions.

  Our Pledge to You

We abide by the information security policy and adheres to keep your private and business information confidential and secure.

Copyright © 2022 Market Research Strategy, All rights reserved.